Erythropoietin (EPO): Began Phase II trials

Dragon Pharmaceuticals Inc. (DRUG), Vancouver, B.C. Product: Erythropoietin (EPO) Business: Generics Therapeutic category: Growth factor Target: Red blood cell precursors Description: Recombinant form...